(Q51915861)

English

Comparison between risperidone, olanzapine, and clozapine in the management of chronic schizophrenia: a naturalistic prospective 12-week observational study.

scientific article published in June 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16783815

Comparison between risperidone, olanzapine, and clozapine in the management of chronic schizophrenia: a naturalistic prospective 12-week observational study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16783815

0 references

chronic schizophrenia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Abraham Weizman

7

object named as

Abraham Weizman

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16783815

author name string

Rael D Strous

1

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16783815

Marina Kupchik

2

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16783815

Suzana Roitman

3

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16783815

Sima Schwartz

4

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16783815

Noach Gonen

5

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16783815

Roberto Mester

6

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16783815

Baruch Spivak

8

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16783815

publication date

1 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16783815

number of pages

9

1 reference

based on heuristic

inferred from page(s)

Human Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16783815

21

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16783815

4

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16783815

235-243

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16783815

Atypical antipsychotic induced weight gain: pathophysiology and management

1 reference

https://api.crossref.org/works/10.1002%2FHUP.764

21 January 2018

The assessment of anxiety states by rating

1 reference

https://api.crossref.org/works/10.1002%2FHUP.764

21 January 2018

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FHUP.764

21 January 2018

A rating scale for drug-induced akathisia

1 reference

https://api.crossref.org/works/10.1002%2FHUP.764

7 January 2021

based on heuristic

inferred from DOI database lookup

Massive increase in serum creatine kinase during olanzapine and quetiapine treatment, not during treatment with clozapine

1 reference

https://api.crossref.org/works/10.1002%2FHUP.764

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of olanzapine on the 5 dimensions of schizophrenia derived by factor analysis: combined results of the North American and international trials.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.764

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1002%2FHUP.764

7 January 2021

based on heuristic

inferred from DOI database lookup

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1002%2FHUP.764

7 January 2021

based on heuristic

inferred from DOI database lookup

Creatine kinase elevations with clozapine

1 reference

https://api.crossref.org/works/10.1002%2FHUP.764

7 January 2021

based on heuristic

inferred from DOI database lookup

Severe Elevations in Serum Creatine Kinase Associated With Clozapine

1 reference

https://api.crossref.org/works/10.1002%2FHUP.764

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FHUP.764

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of antipsychotic therapy on serum lipids: a comprehensive review.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.764

7 January 2021

based on heuristic

inferred from DOI database lookup

A review of the effect of atypical antipsychotics on weight

1 reference

https://api.crossref.org/works/10.1002%2FHUP.764

7 January 2021

based on heuristic

inferred from DOI database lookup

The measurement of suicidality, aggressivity and impulsivity

1 reference

https://api.crossref.org/works/10.1002%2FHUP.764

7 January 2021

based on heuristic

inferred from DOI database lookup

Myotoxicity and neurotoxicity during clozapine treatment

1 reference

https://api.crossref.org/works/10.1002%2FHUP.764

7 January 2021

based on heuristic

inferred from DOI database lookup

Clozapine-induced myotoxicity in patients with chronic psychotic disorders

1 reference

https://api.crossref.org/works/10.1002%2FHUP.764

7 January 2021

based on heuristic

inferred from DOI database lookup

Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.764

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased circulatory dehydroepiandrosterone and dehydroepiandrosterone-sulphate in first-episode schizophrenia: relationship to gender, aggression and symptomatology.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.764

7 January 2021

based on heuristic

inferred from DOI database lookup

Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol

1 reference

https://api.crossref.org/works/10.1002%2FHUP.764

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of gender and brain region on neurosteroid modulation of GABA responses in rats.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.764

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of novel antipsychotics on glucose and lipid levels.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.764

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HUP.764

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16783815

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16783815

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51915861&oldid=1832293217"